Overview

Study of Obatoclax in Previously Untreated Acute Myeloid Leukemia (AML)

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This protocol will evaluate the efficacy of obatoclax in older patients with previously untreated AML.
Phase:
Phase 2
Details
Lead Sponsor:
Gemin X
Treatments:
Obatoclax